The study plans to include a total of 60 patients diagnosed with carpal tunnel syndrome. Patients will be divided into two groups according to the treatment they receive. One group will receive only paraffin treatment, while the other group will receive only ESWT treatment. ESWT will be applied for a total of 5 sessions. Paraffin will be applied for a total of 10 sessions. As assessment tools;

• Measurement of median nerve thickness with ultrasound
• Electromyography
• Visual Analog Scale
• Short Form-36

Evaluations will be made twice by a specialist physician before and after the treatments.

Inclusion Criteria:

• Individuals between the ages of 30-60 who have been diagnosed with CTS by a specialist physician according to international criteria (Those between Stages 1-3),
• Those who have complaints of numbness, tingling, and pain in the first three fingers and half of the fourth finger,
• Phalen Test and Tinel sign or Durkan Test being positive
• Patients who will receive 5 sessions of ESWT application prescribed by a Physical Medicine and Rehabilitation Specialist Physician (for the ESWT group)
• Patients who have been recommended 10 sessions of Paraffin application by a Physical Medicine and Rehabilitation Specialist Physician (for the Paraffin group)

Exclusion Criteria:

• Presence of atrophy in the thenar muscles,
• Insufficient sensory and motor response in the median nerve,
• History of hand and/or wrist injury or surgery,
• Those with cervical stenosis, cervical spondylosis, or cervical radiculopathy,
• Corticosteroids in the carpal tunnel area within the last six months those who have had an injection,
• Pregnancy or diabetes, renal failure, rheumatoid arthritis or hypothyroidism